JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab
BackgroundProgressive multifocal leukoencephalopathy (PML) is an opportunistic infection caused by the JC virus and often fatal. Natalizumab is a highly effective therapy for multiple sclerosis (MS) but is linked to a high incidence of PML. The current metrics used to stratify MS patients at risk fo...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2025-08-01
|
| coleção: | Frontiers in Neurology |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1584083/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|